These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2955749)

  • 21. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of moderately severe virilism of women with Diane and Androcur 10].
    Döring HF; Ilgner M
    Z Hautkr; 1983 May; 58(10):761-7. PubMed ID: 6224353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism.
    Hammerstein J; Meckies J; Leo-Rossberg I; Moltz L; Zielske F
    J Steroid Biochem; 1975 Jun; 6(6):827-36. PubMed ID: 126335
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long-term studies with an anti-androgen/estrogen combination preparation of its effectiveness, liver tolerance and lipid metabolism in females].
    Kaiser E; Gruner S
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):298-303. PubMed ID: 1830560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyproterone acetate - ethinylestradiol treatment of hirsutism, acne, seborrhea and alopecia.
    Nardi M; De Aloysio D; Busacchi P; Flamigni C
    Acta Eur Fertil; 1975 Jun; 6(2):153-65. PubMed ID: 127497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients.
    Inaudi P; D'Ambrogio G; Massafra C; Facchini V; Genazzani AR
    Gynecol Obstet Invest; 1982; 14(2):106-20. PubMed ID: 6288518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
    Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of hirsutism with cyproterone acetate and percutaneous estradiol].
    Rigaud C; Vincens M; Giacomini P; Kuttenn F; Mauvais-Jarvis P
    Presse Med; 1983 Jan; 12(2):73-6. PubMed ID: 6221318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyproterone acetate and the treatment of hirsutism.
    Fraser IS; Shearman RP; Allen JK; McCarron G
    Aust N Z J Obstet Gynaecol; 1983 May; 23(2):93-8. PubMed ID: 6226279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pregnancy carried to term following administration of cyproterone acetate in the 1st trimester].
    Tews G; Arzt W; Mursch-Edlmayr G
    Gynakol Rundsch; 1988; 28(4):193-7. PubMed ID: 2976719
    [No Abstract]   [Full Text] [Related]  

  • 31. Experience in the long-term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: efficacy, metabolic and endocrine effects.
    van Wayjen RG; van den Ende A
    Exp Clin Endocrinol Diabetes; 1995; 103(4):241-51. PubMed ID: 7584530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The treatment of a hyperandrogenic and virilizing state in an elderly female with a synthetic LHRH agonist.
    Parr JH; Abraham RR; Seed M; Short F; Wynn V
    J Endocrinol Invest; 1988 Jun; 11(6):433-6. PubMed ID: 2974852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective medical treatment of common baldness in women.
    Mortimer CH; Rushton H; James KC
    Clin Exp Dermatol; 1984 Jul; 9(4):342-50. PubMed ID: 6235065
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of antiandrogen treatment on the sexuality of women with hyperandrogenism.
    Appelt H; Strauss B
    Psychother Psychosom; 1984; 42(1-4):177-81. PubMed ID: 6240068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic effect at six and twelve months of cyproterone acetate (2 mg) combined with ethinyl estradiol (35 micrograms) in 31 patients.
    Vexiau P; Vexiau-Robert D; Martineau I; Hardy N; Villette JM; Fiet J; Cathelineau G
    Horm Metab Res; 1990 Apr; 22(4):241-5. PubMed ID: 2141001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced serum vitamin B12 levels during oral cyproterone-acetate and ethinyl-oestradiol therapy in women with diffuse androgen-dependent alopecia.
    Ramsay ID; Rushton DH
    Clin Exp Dermatol; 1990 Jul; 15(4):277-81. PubMed ID: 2145099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women.
    Rushton DH; Ramsay ID
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):421-7. PubMed ID: 1424176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiandrogen treatment with cyproterone acetate in with virilizing symptoms].
    Abrahamsson L; Hackl H; Lindström B; Martinik J
    Lakartidningen; 1981 Nov; 78(47):4259-61. PubMed ID: 6460145
    [No Abstract]   [Full Text] [Related]  

  • 39. Testosterone-estradiol binding globulin (TeBG) in hirsute patients treated with cyproterone acetate (CPA) and percutaneous estradiol.
    Vincens M; Mercier-Bodard C; Mowszowicz I; Kuttenn F; Mauvais-Jarvis P
    J Steroid Biochem; 1989 Oct; 33(4A):531-4. PubMed ID: 2530403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Influence on androgens in the serum and urine and on urinary cortisol].
    Nielsen DR; Larsen J; Pedersen IM; Starup J
    Ugeskr Laeger; 1985 Aug; 147(33):2589-93. PubMed ID: 2933857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.